The influence of HAART therapy on bone loss in HIV-infected patients

被引：0
|
作者：
Boccassini, L
Antivalle, M
Santalena, G
Santandrea, S
Sarzi-Puttin, P
Vulpio, L
Landonio, S
Gabris, A
Marrazza, M
Randis, G
Carrabba, M
机构：
[1] L Sacco Univ Hosp, Milan, Italy
[2] Osped L Sacco, Milan, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2003年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：508 / 509
页数：2
相关论文
共 50 条
  • [31] LIPODYSTROPHY SYNDROME IN HIV-INFECTED CHILDREN ON HAART
    Innes, Steve
    Levin, Leon
    Cotton, Mark
    SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE, 2009, (36) : 76 - 80
  • [32] Hypothyroidism in HIV-infected patients who have or have not received HAART
    Quirino, T
    Bongiovanni, M
    Ricci, E
    Chebat, E
    Carradori, S
    Martinelli, C
    Valsecchi, L
    Landonio, S
    Bini, T
    Bonfanti, P
    CLINICAL INFECTIOUS DISEASES, 2004, 38 (04) : 596 - 597
  • [33] Positive outcomes of HAART at 24 months in HIV-infected patients in Cambodia
    Ferradini, Laurent
    Laureillard, Didier
    Prak, Narom
    Ngeth, Chanchhaya
    Fernandez, Marcelo
    Pinoges, Loretxu
    Puertas, Gloria
    Taburet, Anne-Marie
    Ly, Nary
    Rouzioux, Christine
    Balkan, Suna
    Quillet, Catherine
    Delfraissy, Jean-Francois
    AIDS, 2007, 21 (17) : 2293 - 2301
  • [34] HIV patients on antiretroviral therapy (HAART): Bone mass loss and lipodystrophy/lipoatrophy correlation
    Madeddu, Giordano
    Spanu, Angela
    Chessa, Francesca
    Falchi, Antonio
    Madeddu, Giuseppe
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [35] Use of Fibrates in the Management of Hyperlipidemia in HIV-Infected Patients Receiving HAART
    L. Calza
    R. Manfredi
    F. Chiodo
    Infection, 2002, 30 : 26 - 31
  • [36] Neurocognitive impairment and survival in a cohort of HIV-infected patients treated with HAART
    Tozzi, V
    Balestra, P
    Serraino, D
    Bellagamba, R
    Corpolongo, A
    Piselli, P
    Lorenzini, P
    Visco-Comandini, U
    Vlassi, C
    Quartuccio, ME
    Giulianelli, M
    Noto, P
    Galgani, S
    Ippolito, G
    Antinori, A
    Narciso, P
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2005, 21 (08) : 706 - 713
  • [37] Cardiovascular disease risk factors in HIV-Infected patients in the HAART era
    Galli, M
    Ridolfo, AL
    Gervasoni, C
    HIV-ASSOCIATED CARDIOVASCULAR DISEASE: CLINICAL AND BIOLOGICAL INSIGHTS, 2001, 946 : 200 - 213
  • [38] Therapeutic Drug Monitoring of Indinavir in HIV-Infected Patients Undergoing HAART
    P. Langmann
    M. Zilly
    B. Weißbrich
    S. Desch
    T. Väth
    H. Klinker
    Infection, 2002, 30 : 13 - 16
  • [39] Effect of HAART on Salivary Composition and Oxidative Profile in HIV-Infected Patients
    Shahar, Eduardo
    Pollack, Shimon
    Kedem, Eynat
    Hassoun, Gammal
    Nagler, Rafael
    CURRENT HIV RESEARCH, 2008, 6 (05) : 447 - 451
  • [40] Use of fibrates in the management of hyperlipidemia in HIV-infected patients receiving HAART
    Calza, L
    Manfredi, R
    Chiodo, F
    INFECTION, 2002, 30 (01) : 26 - 31
12345